Joinn Laboratories(China)Co Total Assets
Joinn Laboratories(China)Co total assets. Based on the latest financial reports, Joinn Laboratories(China)Co (603127) holds total assets worth CN¥10.04 Billion CNY (≈ $1.47 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Joinn Laboratories(China)Co (603127) total market value for the company's overall valuation and market capitalisation.
Total Assets of Joinn Laboratories(China)Co (2012–2025)
Total assets of Joinn Laboratories(China)Co from 2012 to 2025. This chart illustrates how Joinn Laboratories(China)Co's total assets have evolved over time, based on quarterly financial data. See 603127 stock price and chart for real-time trading data and today's change.
Joinn Laboratories(China)Co - Asset Composition Analysis
Joinn Laboratories(China)Co Total Assets Breakdown (December 2025)
Joinn Laboratories(China)Co total assets breakdown as of December 2025. Joinn Laboratories(China)Co's total assets of CN¥10.04 Billion consist of 54.4% current assets and 45.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.4% |
| Accounts Receivable | CN¥181.13 Million | 1.9% |
| Inventory | CN¥1.41 Billion | 14.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥285.05 Million | 2.9% |
| Goodwill | CN¥54.69 Million | 0.6% |
Asset Composition Trend (2012–2025)
This chart illustrates how Joinn Laboratories(China)Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 603127 working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Joinn Laboratories(China)Co's current assets represent 54.4% of total assets in 2025, an increase from 17.6% in 2012.
- Cash Position: Cash and equivalents constituted 9.4% of total assets in 2025, down from 10.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 11.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 14.6% of total assets.
Joinn Laboratories(China)Co Competitors by Total Assets
Key competitors of Joinn Laboratories(China)Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang DiAn Diagnostics Co
SHE:300244
|
China | CN¥14.08 Billion |
|
Shanghai Runda Med Tech Co
SHG:603108
|
China | CN¥13.79 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.42 Billion |
|
Lumibird SA
PA:LBIRD
|
France | €428.90 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
Leveljump Healthcare Corp
V:JUMP
|
Canada | CA$18.29 Million |
|
Avricore Health Inc
V:AVCR
|
Canada | CA$584.37K |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
Joinn Laboratories(China)Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.02 | 4.61 | 4.90 |
| Quick Ratio | 2.78 | 3.22 | 4.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.81 Billion | CN¥3.97 Billion | CN¥4.28 Billion |
Joinn Laboratories(China)Co - Advanced Valuation Insights
This section examines the relationship between Joinn Laboratories(China)Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.38 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | 3.0% |
| Total Assets | CN¥9.68 Billion |
| Market Capitalization | $4.11 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Joinn Laboratories(China)Co's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Joinn Laboratories(China)Co's assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Joinn Laboratories(China)Co (2012–2025)
The table below shows the annual total assets of Joinn Laboratories(China)Co from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥9.68 Billion ≈ $1.42 Billion |
+3.04% |
| 2024-12-31 | CN¥9.40 Billion ≈ $1.37 Billion |
-6.29% |
| 2023-12-31 | CN¥10.03 Billion ≈ $1.47 Billion |
-3.25% |
| 2022-12-31 | CN¥10.36 Billion ≈ $1.52 Billion |
+21.40% |
| 2021-12-31 | CN¥8.54 Billion ≈ $1.25 Billion |
+305.02% |
| 2020-12-31 | CN¥2.11 Billion ≈ $308.44 Million |
+48.66% |
| 2019-12-31 | CN¥1.42 Billion ≈ $207.47 Million |
+24.22% |
| 2018-12-31 | CN¥1.14 Billion ≈ $167.02 Million |
+21.31% |
| 2017-12-31 | CN¥940.87 Million ≈ $137.68 Million |
+57.58% |
| 2016-12-31 | CN¥597.06 Million ≈ $87.37 Million |
+23.88% |
| 2015-12-31 | CN¥481.99 Million ≈ $70.53 Million |
+6.70% |
| 2014-12-31 | CN¥451.71 Million ≈ $66.10 Million |
+18.84% |
| 2013-12-31 | CN¥380.10 Million ≈ $55.62 Million |
+0.01% |
| 2012-12-31 | CN¥380.06 Million ≈ $55.61 Million |
-- |
About Joinn Laboratories(China)Co
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics… Read more